Pursuing Clinical Trials in Autoimmunity to Expand Treatment Application & Increase Accessibility
Time: 1:30 pm
day: Workshop E
Details:
The dawn of autoimmune applications for cell therapies provides a new and expanded wider patient pool but requires unique considerations and challenges to overcome, compared to oncology.
- Repurposing current cell therapy products to specifically target autoimmune antigens
- Identifying a suitable disease indication to target with optimal clinical outcome
- Understanding unique regulatory requirements for autoimmune disease treatments to streamline IND approval
- Discussing safety considerations and differing needs for autoimmune trials to educate clinicians and streamline trials
